In the competitive field of Organic Medicines, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Organic Medicines technology and learn how to protect your intellectual property.

Patent challenges are becoming increasingly common in the Organic Medicines industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Organic Medicines industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Organic Medicines industry

EP3340971Methods Of Treating Lennox-Gastaut Syndrome Using FenfluramineZOGENIX INTERNATIONAL LIMITEDNov 19, 2024KRAUS & LEDERER PARTGMBB
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, LTD.Nov 14, 2024ACCORD HEALTHCARE LTD
EP4068993Infant Formula With Special Lipid Architecture For Improving Postnatal Growth Of Infants Born To Overweight And Obese MothersN.V. NUTRICIANov 14, 2024SOCIETE DES PRODUITS NESTLE S.A.
EP4159204Novel Pharmaceutical CompositionNOVARTIS AGNov 14, 2024BRAND MURRAY FULLER LLP
EP4159205Novel Pharmaceutical CompositionNOVARTIS AGNov 14, 2024BENDELE, TANJA DR.
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, INC.Nov 13, 2024STADA-ARZNEIMITTEL AKTIENGESELLSCHAFT
EP3632907N-(Azaaryl)Cyclolactam-1-Carboxamide Derivative, Preparation Method Therefor, And Use ThereofABBISKO THERAPEUTICS CO., LTD.Nov 13, 2024DECIPHERA PHARMACEUTICALS, LLC
EP4159204Novel Pharmaceutical CompositionNOVARTIS AGNov 13, 2024TEVA PHARMACEUTICAL INDUSTRIES, LTD.
EP4159205Novel Pharmaceutical CompositionNOVARTIS AGNov 13, 2024TEVA PHARMACEUTICAL INDUSTRIES LTD
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, INC.Nov 12, 2024TEVA PHARMACEUTICAL INDUSTRIES LTD.

To stay ahead in the competitive Organic Medicines industry, companies are constantly innovating. Here are the top patents facing oppositions in the Organic Medicines industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2959894Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS AG23
EP2478907Apr 14, 2021Methods And Compositions For Treating CancerJANSSEN ONCOLOGY, INC.22
EP2425821May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA FARMACÊUTICA LDA.21
EP2425824May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA GMBH20
EP2234617Mar 31, 2021Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA N.V.20
EP2395968Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM INTERNATIONAL GMBH18
EP3626270Oct 11, 2023New UseNOVARTIS AG16
EP2962690Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofCELGENE CORPORATION15
EP3294283Mar 8, 2023Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS AG15
EP2493466Mar 10, 2021Novel Antitumoral Use Of CabazitaxelAVENTIS PHARMA S.A.13